共 21 条
[2]
Collaboration A, 2015, PHYS REV LETT, V114, P19, DOI [10.1103/PhysRevLett.114.191803, DOI 10.1103/PHYSREVLETT.114.191803]
[4]
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2007, 334 (7597)
:786-788A
[10]
Biomarkers, Risk Factors, and Risk Clarifying the Controversy About Surrogate End Points and Clinical Outcomes
[J].
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES,
2015, 8 (05)
:457-459